User login
Mary Thomas, MS, CNS, AOCN, laid out AVAHO’s strategic goals for the coming year. Ms. Thomas pledged to enhance the value of AVAHO to its stakeholders, raise awareness of AVAHO inside and outside the organization, increase membership, and evolve the organization’s business model to ensure financial sustainability.
In closing the meeting, Ms. Thomas encouraged members, “I challenge each and every one of you when you go back to your facility, make sure that everyone that is involved in hematologic and oncologic care at your facility knows about this organization.”
The group is now moving towards the 2017 annual meeting, which will be held in Denver, September 15 to17, 2017. The meeting theme will be grounded in the every-day realities of providing cancer and hematology care in the VA: evidence-based practices that ensure patient values are maintained and utilizing clinical expertise.
Related: AVAHO Education Chair Mary Thomas on the AVAHO Meeting Program
Rusty Crawford, B Pharm, was named president-elect and Karen Clark Griffith, RN, PhD, will continue to be the organization's treasurer. In addition, Drew Moghanaki, MD, MPH; Tina Gill, MA; and William Wachsman, MD; were all elected to the AVAHO Board of Directors.
Outgoing president Anita Aggrawal also announced the creation of a new young investigator grant for research for $10,000, which will be selected in the coming year.
Awards were given for the top poster abstracts presented at the conference. The top poster from Klein and colleagues sought to determine the efficacy of inhibition of mitochondrial antioxidant defense against mesothelioma and whether the cyclin-dependent kinase 4 inhibitor palbociclib sensitizes mesothelioma cells to inhibition of mitochondrial antioxidant defense.
Related: New Protocol Aims to Evaluate Medication Adherence
The second-placed poster from Ahmed Halwani, MD, and colleagues develop a novel approach for extracting, retrieving, and validating clinical lab information from the VA Corporate Data Warehouse, in the hope of utilizing the data for better analysis.
The final poster abstract that was recognized at the conference was created by Cindy Bowman, MSN. The abstract outlined a patient navigation program for veterans with head and neck cancer. The program is focused on “providing holistic patient-centered care, eliminating fragmented care and delays, and decreasing emotional distress and healthcare cost.”
Mary Thomas, MS, CNS, AOCN, laid out AVAHO’s strategic goals for the coming year. Ms. Thomas pledged to enhance the value of AVAHO to its stakeholders, raise awareness of AVAHO inside and outside the organization, increase membership, and evolve the organization’s business model to ensure financial sustainability.
In closing the meeting, Ms. Thomas encouraged members, “I challenge each and every one of you when you go back to your facility, make sure that everyone that is involved in hematologic and oncologic care at your facility knows about this organization.”
The group is now moving towards the 2017 annual meeting, which will be held in Denver, September 15 to17, 2017. The meeting theme will be grounded in the every-day realities of providing cancer and hematology care in the VA: evidence-based practices that ensure patient values are maintained and utilizing clinical expertise.
Related: AVAHO Education Chair Mary Thomas on the AVAHO Meeting Program
Rusty Crawford, B Pharm, was named president-elect and Karen Clark Griffith, RN, PhD, will continue to be the organization's treasurer. In addition, Drew Moghanaki, MD, MPH; Tina Gill, MA; and William Wachsman, MD; were all elected to the AVAHO Board of Directors.
Outgoing president Anita Aggrawal also announced the creation of a new young investigator grant for research for $10,000, which will be selected in the coming year.
Awards were given for the top poster abstracts presented at the conference. The top poster from Klein and colleagues sought to determine the efficacy of inhibition of mitochondrial antioxidant defense against mesothelioma and whether the cyclin-dependent kinase 4 inhibitor palbociclib sensitizes mesothelioma cells to inhibition of mitochondrial antioxidant defense.
Related: New Protocol Aims to Evaluate Medication Adherence
The second-placed poster from Ahmed Halwani, MD, and colleagues develop a novel approach for extracting, retrieving, and validating clinical lab information from the VA Corporate Data Warehouse, in the hope of utilizing the data for better analysis.
The final poster abstract that was recognized at the conference was created by Cindy Bowman, MSN. The abstract outlined a patient navigation program for veterans with head and neck cancer. The program is focused on “providing holistic patient-centered care, eliminating fragmented care and delays, and decreasing emotional distress and healthcare cost.”
Mary Thomas, MS, CNS, AOCN, laid out AVAHO’s strategic goals for the coming year. Ms. Thomas pledged to enhance the value of AVAHO to its stakeholders, raise awareness of AVAHO inside and outside the organization, increase membership, and evolve the organization’s business model to ensure financial sustainability.
In closing the meeting, Ms. Thomas encouraged members, “I challenge each and every one of you when you go back to your facility, make sure that everyone that is involved in hematologic and oncologic care at your facility knows about this organization.”
The group is now moving towards the 2017 annual meeting, which will be held in Denver, September 15 to17, 2017. The meeting theme will be grounded in the every-day realities of providing cancer and hematology care in the VA: evidence-based practices that ensure patient values are maintained and utilizing clinical expertise.
Related: AVAHO Education Chair Mary Thomas on the AVAHO Meeting Program
Rusty Crawford, B Pharm, was named president-elect and Karen Clark Griffith, RN, PhD, will continue to be the organization's treasurer. In addition, Drew Moghanaki, MD, MPH; Tina Gill, MA; and William Wachsman, MD; were all elected to the AVAHO Board of Directors.
Outgoing president Anita Aggrawal also announced the creation of a new young investigator grant for research for $10,000, which will be selected in the coming year.
Awards were given for the top poster abstracts presented at the conference. The top poster from Klein and colleagues sought to determine the efficacy of inhibition of mitochondrial antioxidant defense against mesothelioma and whether the cyclin-dependent kinase 4 inhibitor palbociclib sensitizes mesothelioma cells to inhibition of mitochondrial antioxidant defense.
Related: New Protocol Aims to Evaluate Medication Adherence
The second-placed poster from Ahmed Halwani, MD, and colleagues develop a novel approach for extracting, retrieving, and validating clinical lab information from the VA Corporate Data Warehouse, in the hope of utilizing the data for better analysis.
The final poster abstract that was recognized at the conference was created by Cindy Bowman, MSN. The abstract outlined a patient navigation program for veterans with head and neck cancer. The program is focused on “providing holistic patient-centered care, eliminating fragmented care and delays, and decreasing emotional distress and healthcare cost.”